Future oncology
The most recent articles from:
Future Oncol
-
We retrospectively analyzed data from patients who had been treated with trabectedin at our institution between April 2009 and August 2011. ⋯ Treatment with trabectedin is effective and well tolerated in heavily pretreated soft tissue sarcoma patients. Tapering dexamethasone courses and switching trabectedin administration to an every 4 weeks schedule effectively dealt with persistent fatigue without compromising effectiveness.